DRNA
Dicerna Pharmaceuticals Inc
Bain Capital Life Sciences Investors, LLC bought $2.0M of Dicerna Pharmaceuticals Inc
Director and 10% owner
Bought$1,995,000
$7.00Price
285,000Shares
+3%Stake
What DRNA did for a copier
Prices for DRNA after this filing aren't in yet.
Bain Capital Life Sciences Investors, LLC's record
4 other buys with 3 months of prices since 2018: on average −38.3% against the S&P 500, and 0 of 4 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Dec 18. Filed Tue, Dec 19. Not investment advice.